ARTICLE | Company News
NovaThera, Pharming deal
July 18, 2005 7:00 AM UTC
The companies will combine NovaThera's biomaterials with PHARM's recombinant proteins for potential use in tissue engineering and regenerative medicine. PHARM will have commercial rights to resulting ...